TELA

TELA Bio, Inc. Common Stock

1.09

USD

TELA Earnings Reports

Positive Surprise Ratio

TELA beat 7 of 25 last estimates.

28%

Next Report

Date of Next Report

Mar 18, 2026

Estimate for Q4 25 (Revenue/ EPS)

$21.47M

-$0.18

Implied change from Q3 25 (Revenue/ EPS)

+3.77%

-5.26%

Implied change from Q4 24 (Revenue/ EPS)

+21.64%

-21.74%

TELA Bio, Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, TELA reported earnings of -0.19 USD per share (EPS) for Q3 25, beating the estimate of -0.20 USD, resulting in a 6.40% surprise. Revenue reached 20.69 million, compared to an expected 22.22 million, with a -6.91% difference. The market reacted with a -9.97% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.18 USD, with revenue projected to reach 21.47 million USD, implying an decrease of -5.26% EPS, and increase of 3.77% in Revenue from the last quarter.

FAQ

What were TELA Bio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, TELA Bio, Inc. Common Stock reported EPS of -$0.19, beating estimates by 6.4%, and revenue of $20.69M, -6.91% below expectations.

How did the market react to TELA Bio, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -9.97%, changed from $1.11 before the earnings release to $1.00 the day after.

When is TELA Bio, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 18, 2026.

What are the forecasts for TELA Bio, Inc. Common Stock's next earnings report?

Based on 7 analysts, TELA Bio, Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $21.47M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.